Covance Financial Statements
Covance Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Covance Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,631.5 | 1,406.1 | 1,250.4 |
| Gross Profit ($ mil.) | 528.7 | 458.0 | 401.3 |
| Operating Income ($ mil.) | 228.6 | 193.2 | 175.1 |
| Total Net Income ($ mil.) | 175.9 | 145.0 | 119.6 |
| Diluted EPS (Net Income) | 2.71 | 2.24 | 1.88 |
Covance Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 461.8 | 434.0 | 435.7 |
| Gross Profit ($ mil.) | 150.0 | 139.1 | 137.1 |
| Operating Income ($ mil.) | 67.5 | 62.7 | 61.0 |
| Total Net Income ($ mil.) | 50.9 | 49.1 | 50.9 |
| Diluted EPS (Net Income) | 0.80 | 0.76 | 0.78 |
Covance Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.49 | 1.48 | 1.56 |
| Price/Earnings Ratio | 31.26 | 22.56 | 15.82 |
| Price/Book Ratio | 5.41 | 2.77 | 1.52 |
| Price/Cash Flow Ratio | 21.17 | 14.73 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Covance Financial Ratios
Covance Competitive Intelligence
| Charles River Laboratories | MDS | Pharmaceutical Product Development | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1,230.6 | 1,210.0 | 1,414.5 |
| Employees | 8,500 | 5,500 | -- |
| Market Cap ($ mil.) | 4,609.5 | -- | 4,990.5 |
Competitive Landscape
